594844-56-1 Usage
Uses
Used in Organic Synthesis:
(4-Nitro-1H-indol-1-yl)acetic acid is used as a key intermediate in organic synthesis for the production of various organic compounds. Its versatile structure allows for the creation of a wide range of molecules with different functional groups, making it a valuable building block in the synthesis of complex organic molecules.
Used in Pharmaceutical Research:
(4-Nitro-1H-indol-1-yl)acetic acid is utilized as a reagent in the preparation of pharmaceuticals. Its unique structure and functional groups make it a promising candidate for the development of new drugs and therapeutic agents. Researchers can use (4-Nitro-1H-indol-1-yl)acetic acid to explore its potential in treating various diseases and conditions, as well as to enhance the efficacy and safety of existing medications.
Used in Chemical Research:
(4-Nitro-1H-indol-1-yl)acetic acid is also used in chemical research to study the properties and reactions of nitro-containing compounds. Its presence in the molecule makes it potentially explosive, which requires careful handling and specialized knowledge to work with safely. This characteristic can be harnessed to investigate the behavior of nitro groups in chemical reactions and their potential applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 594844-56-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,9,4,8,4 and 4 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 594844-56:
(8*5)+(7*9)+(6*4)+(5*8)+(4*4)+(3*4)+(2*5)+(1*6)=211
211 % 10 = 1
So 594844-56-1 is a valid CAS Registry Number.
594844-56-1Relevant academic research and scientific papers
ESTER COMPOUND AND MEDICINAL USE THEREOF
-
Page 181, (2008/06/13)
A novel therapeutic agent for hyperlipidemia, which is an ester compound represented by the formula (1") (wherein ???R1 and R2 are each hydrogen atom or optionally substituted aryl, etc.; ???X is -COO- or -CON(R10)-; ???R3 and R4 are each hydrogen atom, C1-C6 alkyl or C1-C6 alkoxy, etc.; ???R5, R6 and R7 are each hydrogen atom, C1-C6 alkyl or C1-C6 alkoxy, etc.; ???R8 and R9 are each independently hydrogen atom, C1-C6 alkyl, -CON(R18)(R19) or -COO(R20), etc.; ???ring A, ring B and ring C are each independently aryl or heterocycle residue, etc.; ???Alk1 and Alk2 are each independently alkanediyl, etc.; ???l and m are each an integer of 0 or 1 to 3) or a prodrug thereof, or a pharmaceutically acceptable salt of either. The therapeutic agent selectively inhibits MTP in the small intestine, thus causes no such side effect as a fatty liver.
